Senolytic therapies restore regenerative capacity in aging teeth

Loss of NFATC1 activity in dental pulp mesenchymal stromal cells emerges as the key driver of tooth aging, a finding validated through in vivo genetic tools, advanced 3D imaging, and serial histological analysis. As this protein declines, teeth become brittle, fracture-prone, and lose regenerative capacity—a phenomenon the dental community has only recently begun to investigate in depth. The critical discovery is that senescent cells in pulpal tissue function as the primary agent of dysfunction: when researchers induced NFATC1 loss in young adult mice, they accelerated dental aging, exactly replicating the degenerative phenotype seen in natural aging. Senolytic therapies—drugs that selectively clear senescent cells—restored both regenerative capacity and structural integrity, preserving tooth vitality. This mechanism parallels age-related bone degeneration, where senescent skeletal stem cells create inflammatory microenvironments that impair repair. For the longevity-focused reader, the result offers concrete therapeutic leverage: intervening on pulpal senescence conserves teeth while challenging an aging marker once considered immutable.